Increased levels of circulating platelet derived microparticles in Crohn's disease patients

References

• Danese S, Motte Cd Cde L, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol. 2004;99:938–945.
   PubMed Web of Science ®Google Scholar
• Harries AD, Beeching NJ, Rogerson SJ, et al. The platelet count as a simple measure to distinguish inflammatory bowel disease from infective diarrhoea. J Infect. 1991;22:247–250.
   PubMed Web of Science ®Google Scholar
• Collins CE, Rampton DS. Review article: platelets in inflammatory bowel disease–pathogenetic role and therapeutic implications. Aliment Pharmacol Ther. 1997;11:237–247.
   PubMed Web of Science ®Google Scholar
• Collins CE, Rampton DS, Rogers J, et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1997;9:1213–1217.
   PubMed Web of Science ®Google Scholar
• Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007;102:174–186.
   PubMed Web of Science ®Google Scholar
• Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001;96:776–781.
   PubMed Web of Science ®Google Scholar
• Nomura S, Shimizu M. Clinical significance of procoagulant microparticles. J Intens Care. 2015;3:2.
   PubMed Web of Science ®Google Scholar
• Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol. 2007;137:36–48.
   PubMed Web of Science ®Google Scholar
• Nomura S, Shouzu A, Omoto S, et al. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol. 2000;121:437–443.
   PubMed Web of Science ®Google Scholar
• Inami N, Nomura S, Kikuchi H, et al. P-selectin and platelet-derived microparticles associated with monocyte activation markers in patients with pulmonary embolism. Clin Appl Thromb Hemost. 2003;9:309–316.
   PubMed Web of Science ®Google Scholar
• Kanellopoulou T, Alexopoulou A, Kontopidou F, et al. The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking. Ann Gastroenterol. 2016;29:201–7.
   PubMedGoogle Scholar
• Sellam J, Proulle V, Jungel A, et al. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther. 2009;11:R156.
   PubMed Web of Science ®Google Scholar
• Andoh A, Tsujikawa T, Hata K, et al. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol. 2005;100:2042–2048.
   PubMed Web of Science ®Google Scholar
• Chamouard P, Desprez D, Hugel B, et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci. 2005;50:574–580.
   PubMed Web of Science ®Google Scholar
• Palkovits J, Novacek G, Kollars M, et al. Tissue factor exposing microparticles in inflammatory bowel disease. J Crohns Colitis. 2013;7:222–229.
   PubMed Web of Science ®Google Scholar
• Pamuk GE, Vural O, Turgut B, et al. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol. 2006;81:753–759.
   PubMed Web of Science ®Google Scholar
• Leonetti D, Reimund JM, Tesse A, et al. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One. 2013;8:e73088.
   Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625–1629.
   PubMed Web of Science ®Google Scholar
• Michelson AD. Flow cytometry: a clinical test of platelet function. Blood. 1996;87:4925–4936.
   PubMed Web of Science ®Google Scholar
• Lacroix R, Robert S, Poncelet P, et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost. 2010;8:2571–2574.
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012;380:1590–1605.
   PubMed Web of Science ®Google Scholar
• Ordas I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380:1606–1619.
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640.
   PubMed Web of Science ®Google Scholar
• Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1993;94:174–181.
   PubMed Web of Science ®Google Scholar
• Monteleone I, Vavassori P, Biancone L, et al. Immunoregulation in the gut: success and failures in human disease. Gut. 2002;50:III60–III64.
   PubMedGoogle Scholar
• Holme PA, Solum NO, Brosstad F, et al. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets. Thromb Haemost. 1998;79:389–394.
   PubMed Web of Science ®Google Scholar
• Fourcade O, Simon MF, Viode C, et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 1995;80:919–927.
   PubMed Web of Science ®Google Scholar
• Ramstrom S, Sodergren AL, Tynngard N, et al. Platelet function determined by flow cytometry: new perspectives? Semin Thromb Hemost. 2016;42:268–281.
   PubMed Web of Science ®Google Scholar
• Michelson AD, Benoit SE, Kroll MH, et al. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood. 1994;83:3562–3573.
   PubMed Web of Science ®Google Scholar
• Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood. 1998;92:4446–4452.
   PubMed Web of Science ®Google Scholar
• Kaplan R, Gabbeta J, Sun L, et al. Combined defect in membrane expression and activation of platelet GPIIb-IIIa complex without primary sequence abnormalities in myeloproliferative disease. Br J Haematol. 2000;111:954–964.
   PubMed Web of Science ®Google Scholar
• Irving PM, Macey MG, Shah U, et al. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:361–372.
   PubMed Web of Science ®Google Scholar
• Desreumaux P. Understanding the mechanism of 5-ASA in treating colonic inflammation. Gastroenterol Hepatol (NY). 2008;4:319–320.
   PubMedGoogle Scholar
• Carty E, MacEy M, Rampton DS. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther. 2000;14:1169–1179.
   PubMed Web of Science ®Google Scholar
• Liverani E, Banerjee S, Roberts W, et al. Prednisolone exerts exquisite inhibitory properties on platelet functions. Biochem Pharmacol. 2012;83:1364–1373.
   PubMed Web of Science ®Google Scholar
• ten Hove T, van Montfrans C, Peppelenbosch MP, et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut. 2002;50:206–211.
   PubMed Web of Science ®Google Scholar
• Cornillie F, Shealy D, D'Haens G, et al. Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther. 2001;15:463–473.
   PubMed Web of Science ®Google Scholar